Photocure ASA PHCUF
5.65 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
6.63 Day range 6.63
5.58 52-week range 7.39
- YTD
- -19.29%
- 1 year
- +1.25%
News
seekingalpha.com Photocure ASA (PHCUF) Q3 2026 Earnings Call Transcript Photocure ASA (PHCUF) Q3 2026 Earnings Call Transcript
seekingalpha.com Photocure ASA (PHCUF) Q2 2026 Earnings Call Transcript Photocure ASA (PHCUF) Q2 2026 Earnings Call Transcript
seekingalpha.com Photocure ASA (PHCUF) M&A Call Transcript Photocure ASA (PHCUF) M&A Call Transcript
prnewswire.com Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics OSLO, Norway, June 4, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), a leader in bladder cancer diagnostics, today announced the signing and successful completion of its acquisition of Vesica Health,…
seekingalpha.com Photocure ASA (PHCUF) Q1 2026 Earnings Call Transcript Photocure ASA (PHCUF) Q1 2026 Earnings Call Transcript
prnewswire.com Photocure ASA: Results for the first quarter of 2026 OSLO, Norway, May 7, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 139.0 million in the first quarter of 2026 (Q1 2025: NOK 125.3 million), and an…
prnewswire.com Photocure ASA: Update on Regulatory Classification for OAY Equipment OSLO, Norway, April 13, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announced that the U.S. Food and Drug Administration (FDA) has communicated to Photocure that it plans to issue a proposed…
seekingalpha.com Photocure ASA (PHCUF) Q4 2025 Earnings Call Transcript Photocure ASA (PHCUF) Q4 2025 Earnings Call Transcript
prnewswire.com Photocure ASA: Results for the fourth quarter of 2025 OSLO, Norway, Feb. 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024: NOK 128.6 million), and a…
seekingalpha.com Photocure ASA (PHCUF) Q3 2025 Earnings Call Transcript Photocure ASA (OTCPK:PHCUF) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants Daniel Schneider - President & CEO Erik Dahl - Chief Financial Officer Presentation Daniel…
prnewswire.com Photocure ASA: Results for the third quarter of 2025 OSLO, Norway , Oct. 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 134.1 million in the third quarter of 2025 (Q3 2024: NOK 120.1 million), and…
prnewswire.com Photocure ASA: Results for the second quarter of 2025 OSLO, Norway , July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 135.6 million in the second quarter of 2025 (Q2 2024: NOK 122.4 million), and…
prnewswire.com Photocure ASA: Results for the first quarter of 2025 OSLO, Norway , May 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK 116.8 million), and an…
prnewswire.com Photocure ASA: Results for the fourth quarter of 2024 OSLO, Norway , Feb. 19, 2025 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 128.6 million in the fourth quarter of 2024 (Q4 2023: NOK 114.2 million) and…
prnewswire.com Photocure ASA: Results for the third quarter of 2024 OSLO, Norway , Nov. 13, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 120.1 million in the third quarter of 2024 (Q3 2023: NOK 107.3 million), and…